Disclosures Page- ACI 2017 Modules

Advances in Cancer Immunotherapy™ 2017 Video Series


Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of these CME activities:

Name of Faculty or Presenter Reported Financial Relationship
Monica Thakar, MD Miltenyi Biotec, Contracted Research
Marlana Orloff, MD Castle Biosciences, Inc., Immunocore Limited, Consulting Fees
Ticiana A. Leal, MD Genentech, Inc., Takeda Pharmaceutical Company Limited, Consulting Fees
Douglas G. McNeel, MD, PhD Clinical Research for UW-Madison, Dendreon Corporation Janssen, Novartis and Medivation
Timothy S. Fenske, MD Celgene Corporation, Pharmacyclics LLC, Sanofi, Contracted Research; Celgene Corporation, Sanofi, Fees for Non-CME/CE Services Received Directly from a Commercial Interest or their Agents
Joshua M. Bauml, MD AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene Corporation, Genentech, Inc., Guardant Health, Inc., Merck & Co., Inc., Consulting Fees; Carevive Systems, Bayer AG, Merck & Co., Inc., Novartis AG, Contracted Research
Sigrun Hallmeyer, MD Bristol-Myers Squibb, Cardinal Health, Pfizer, Consulting Fees ; Bristol-Myers Squibb, Pfizer, Fees for Non-CME/CE Services Received Directly from a Commercial Interest or their Agents
Justine V. Cohen, MD No relevant financial relationships to disclose
Ellen Napier, CRNP No relevant financial relationships to disclose
Kathleen Madden, RN, MSN, FNP-BC Bristol-Myers Squibb, Merck & Co., Inc., Fees for Non-CME/CE Services Received Directly from a Commercial Interest or their Agents
Ronny M. Otero, MD, FAAEM No relevant financial relationships to disclose


The Planning Committee reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Name of Planning Committee

Reported Financial Relationship

Asim Amin, MD, PhD

Bristol-Myers Squibb, Merck & Co., Inc., Pfizer Inc., Fees for Non-CME/CE Services Received Directly from a Commercial Interest or their Agents; Bristol-Myers Squibb, Dynavax Technologies Corporation, Merck & Co., Inc., Contracted Research

John D. Powderly II, MD, CPI

Carolina BioOncology Institute, Salary; Biocytics,  Receipt of Intellectual Property Rights/Patent Holder; AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb, Corvus Pharmaceuticals, Curis, Inc., Genentech, Inc., Consulting Fees; Bristol-Myers Squibb, Genentech, Inc., Merck & Co., Inc., Fees for Non-CME/CE Services Received Directly from a Commercial Interest or their Agents; AbbVie Inc., AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb, Corvus Pharmaceuticals, EMD Serono, Inc., Genentech, Inc., Incyte Corporation, MacroGenics, Inc., Contracted Research; bluebird bio, Inc., Lion Biotechnologies, Inc., Kite Pharma, Juno Therapeutics, ZIOPHARM Oncology, Inc., Ownership Interest

Thomas Tobin, MD, MBA, FAAEM

No relevant financial relationships to disclose

Joseph W. Fay, MD

No relevant financial relationships to disclose

Brian I. Rini MD

Merck & Co., Inc., Pfizer Inc., Consulting Fees; Genentech, Inc., Merck & Co., Inc., Pfizer Inc., Contracted Research

Laura S. Wood, RN, MSN, OCN

Bristol-Myers Squibb, Fees for Non-CME/CE Services Received Directly from a Commercial Interest or their Agents

Keith L. Knutson, PhD

No relevant financial relationships to disclose

Lee Schwartzberg, MD, FACP

Bristol-Myers Squibb, Consulting Fees

Eleni Yeatras, RPh, BCOP

No relevant financial relationships to disclose

Hideho Okada, MD, PhD

Intrexon, Stemline Therapeutics, Inc., Royalties; Novartis AG, Receipt of Intellectual Property Rights/Patent Holder; INC Research, Gerson Lehrman Group, Inc., Contracted Research

Alexander Spira, MD, PhD

Ariad Pharmaceuticals, Inc., Consulting Fees; Hoffmann-La Roche Ltd, Eli Lilly and Company, Fees for Non-CME/CE Services Received Directly from a Commercial Interest or their Agents; AbbVie Inc., ARIAD Pharmaceuticals, AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb, Clovis Oncology, CytomX Therapeutics, Inc., Hoffmann-La Roche Ltd, MedImmune, Merck & Co., Inc., Mirati Therapeutics, Inc., Contracted Research


The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

The following PIM planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi Smelker-Mitchek, MBA, MSN, RN, and Jan Schultz, MSN, RN, CHCP have nothing to disclose hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

The following SITC planners and managers, Tara Withington, CAE, Executive Director of SITC, Nadine M. Couto, CMP; Alicia Schuessler, CAE; Lianne Wiggins, Cari Grulke; Michelle Johnson; Kim Mitschke; and Aliya Zouine – hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.